Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Sharps Technology
Recent news which mentions Sharps Technology
Pending $400 Million Purchase Agreement To Advance Sharps Into Large Prefillable Syringe Market With Differentiated Copolymer Syringe Systems
November 28, 2023
Tickers
STSS
Tags
Biotech
Partner Content
General
From
Benzinga
Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal
October 05, 2023
Tickers
STSS
Tags
General
News
Biotech
From
Benzinga
Sharps Technology Issues Update Letter To Shareholders From CEO Robert Hayes
April 17, 2023
Tickers
STSS
STSSW
Tags
STSSW
Sharps Technology
Markets
From
Benzinga
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
March 01, 2023
Tickers
BDX
CAH
STSS
TRUMY
Tags
Market News
Penny Stocks
STSS
From
Benzinga
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
February 15, 2023
Tickers
BDX
CAH
NVO
STSS
Tags
Market News
Benzinga
STSS
From
Benzinga
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
January 17, 2023
Tickers
BDX
CAH
STSS
TRUMY
Tags
STSS
Benzinga
Penny Stocks
From
Benzinga
Sharps Technology To Launch Next-Gen Prefillable Syringe Systems In Collaboration With Nephron Pharmaceuticals In 2023
January 11, 2023
Tickers
STSS
STSSW
Tags
News
Biotech
General
From
Benzinga
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
January 09, 2023
Tickers
BDX
CAH
NVO
STSS
Tags
TRUMY
Sharps Technology
Markets
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.